{"entity":{"type":"insider","cik":"0001283518","url":"/insider/0001283518","json_url":"/insider/0001283518.json","name":"Frost Gregory Ian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":369,"n_filings":25,"first":"2004-08-18","last":"2014-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Frost Gregory Ian","source":"filing","n_filings":24,"first_seen":"2005-08-23","last_seen":"2014-03-04"},{"name":"FROST GREGORY IAN","source":"filing","n_filings":1,"first_seen":"2004-08-18","last_seen":"2004-08-18"}],"transactions":[{"id":7080095,"accession":"0001498902-14-000023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001498902-14-000023","line_url":"/filing/0001498902-14-000023#line-3","is_derivative":false,"issuer_cik":"0001283518","issuer_name":"INTREXON CORP","issuer_ticker":"XON","issuer_name_source":null,"issuer_url":"/issuer/0001283518","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Officer (SVP--Health Sector)","role_mark":"O","role_mark_label":"Officer (SVP--Health Sector)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP--Health Sector","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58000.0,"shares_display":"58,000","price_per_share":26.0433,"price_display":"26.04","price_state":"stated","total_value":1510511.4,"total_display":"1,510,511.40","total_whole":"1,510,511","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-04","scope":"insider"},{"id":7080093,"accession":"0001498902-14-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001498902-14-000023","line_url":"/filing/0001498902-14-000023#line-2","is_derivative":false,"issuer_cik":"0001283518","issuer_name":"INTREXON CORP","issuer_ticker":"XON","issuer_name_source":null,"issuer_url":"/issuer/0001283518","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Officer (SVP--Health Sector)","role_mark":"O","role_mark_label":"Officer (SVP--Health Sector)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP--Health Sector","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":24.5862,"price_display":"24.59","price_state":"stated","total_value":86051.7,"total_display":"86,051.70","total_whole":"86,052","shares_owned_after":42000.0,"shares_owned_after_display":"42,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-04","scope":"insider"},{"id":7080090,"accession":"0001498902-14-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001498902-14-000023","line_url":"/filing/0001498902-14-000023#line-1","is_derivative":false,"issuer_cik":"0001283518","issuer_name":"INTREXON CORP","issuer_ticker":"XON","issuer_name_source":null,"issuer_url":"/issuer/0001283518","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Officer (SVP--Health Sector)","role_mark":"O","role_mark_label":"Officer (SVP--Health Sector)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP--Health Sector","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38500.0,"shares_display":"38,500","price_per_share":25.9296,"price_display":"25.93","price_state":"stated","total_value":998289.6,"total_display":"998,289.60","total_whole":"998,290","shares_owned_after":38500.0,"shares_owned_after_display":"38,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-28","filed_date":"2014-03-04","scope":"insider"},{"id":3446998,"accession":"0001483813-12-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001483813-12-000026","line_url":"/filing/0001483813-12-000026#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":11000.0,"total_display":"11,000.00","total_whole":"11,000","shares_owned_after":3555331.0,"shares_owned_after_display":"3,555,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-13","filed_date":"2012-08-14","scope":"insider"},{"id":9018298,"accession":"0001483813-11-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001483813-11-000019","line_url":"/filing/0001483813-11-000019#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":35040.0,"total_display":"35,040.00","total_whole":"35,040","shares_owned_after":3536866.0,"shares_owned_after_display":"3,536,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-10","scope":"insider"},{"id":2513897,"accession":"0001418145-08-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001418145-08-000024","line_url":"/filing/0001418145-08-000024#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230000.0,"shares_display":"230,000","price_per_share":6.06,"price_display":"6.06","price_state":"stated","total_value":1393800.0,"total_display":"1,393,800.00","total_whole":"1,393,800","shares_owned_after":3530866.0,"shares_owned_after_display":"3,530,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-20","filed_date":"2008-03-24","scope":"insider"},{"id":7197094,"accession":"0001418145-07-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001418145-07-000012","line_url":"/filing/0001418145-07-000012#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9137.0,"shares_display":"9,137","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":63959.0,"total_display":"63,959.00","total_whole":"63,959","shares_owned_after":3149606.0,"shares_owned_after_display":"3,149,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-20","filed_date":"2007-12-21","scope":"insider"},{"id":8584302,"accession":"0001418145-07-000006","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001418145-07-000006","line_url":"/filing/0001418145-07-000006","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":7.624632,"price_display":"7.62","price_state":"stated","total_value":76246.32,"total_display":"76,246.32","total_whole":"76,246","shares_owned_after":3116406.0,"shares_owned_after_display":"3,116,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-21","filed_date":"2007-11-21","scope":"insider","n_lines":20},{"id":7319963,"accession":"0001418145-07-000002","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-30","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":7.93,"price_display":"7.93","price_state":"stated","total_value":7137.0,"total_display":"7,137.00","total_whole":"7,137","shares_owned_after":3114306.0,"shares_owned_after_display":"3,114,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319961,"accession":"0001418145-07-000002","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-29","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":613.0,"shares_display":"613","price_per_share":7.62,"price_display":"7.62","price_state":"stated","total_value":4671.06,"total_display":"4,671.06","total_whole":"4,671","shares_owned_after":3120293.0,"shares_owned_after_display":"3,120,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319959,"accession":"0001418145-07-000002","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-28","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":7.96,"price_display":"7.96","price_state":"stated","total_value":4776.0,"total_display":"4,776.00","total_whole":"4,776","shares_owned_after":3113106.0,"shares_owned_after_display":"3,113,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319957,"accession":"0001418145-07-000002","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-27","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":7.94,"price_display":"7.94","price_state":"stated","total_value":4764.0,"total_display":"4,764.00","total_whole":"4,764","shares_owned_after":3113706.0,"shares_owned_after_display":"3,113,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319955,"accession":"0001418145-07-000002","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-26","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":7.87,"price_display":"7.87","price_state":"stated","total_value":4722.0,"total_display":"4,722.00","total_whole":"4,722","shares_owned_after":3116106.0,"shares_owned_after_display":"3,116,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319953,"accession":"0001418145-07-000002","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-25","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":3111506.0,"shares_owned_after_display":"3,111,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319951,"accession":"0001418145-07-000002","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-24","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":3985.0,"total_display":"3,985.00","total_whole":"3,985","shares_owned_after":3112606.0,"shares_owned_after_display":"3,112,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319950,"accession":"0001418145-07-000002","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-23","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":7.84,"price_display":"7.84","price_state":"stated","total_value":3920.0,"total_display":"3,920.00","total_whole":"3,920","shares_owned_after":3116906.0,"shares_owned_after_display":"3,116,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319948,"accession":"0001418145-07-000002","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-22","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.98,"price_display":"7.98","price_state":"stated","total_value":3192.0,"total_display":"3,192.00","total_whole":"3,192","shares_owned_after":3112206.0,"shares_owned_after_display":"3,112,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319946,"accession":"0001418145-07-000002","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-21","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.9,"price_display":"7.90","price_state":"stated","total_value":3160.0,"total_display":"3,160.00","total_whole":"3,160","shares_owned_after":3115406.0,"shares_owned_after_display":"3,115,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319945,"accession":"0001418145-07-000002","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-20","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.82,"price_display":"7.82","price_state":"stated","total_value":3128.0,"total_display":"3,128.00","total_whole":"3,128","shares_owned_after":3117406.0,"shares_owned_after_display":"3,117,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319943,"accession":"0001418145-07-000002","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-19","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.8,"price_display":"7.80","price_state":"stated","total_value":3120.0,"total_display":"3,120.00","total_whole":"3,120","shares_owned_after":3117806.0,"shares_owned_after_display":"3,117,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319941,"accession":"0001418145-07-000002","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-18","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":3052.0,"total_display":"3,052.00","total_whole":"3,052","shares_owned_after":3119893.0,"shares_owned_after_display":"3,119,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319939,"accession":"0001418145-07-000002","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-17","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.88,"price_display":"7.88","price_state":"stated","total_value":2364.0,"total_display":"2,364.00","total_whole":"2,364","shares_owned_after":3115806.0,"shares_owned_after_display":"3,115,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319938,"accession":"0001418145-07-000002","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-16","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":2325.0,"total_display":"2,325.00","total_whole":"2,325","shares_owned_after":3118606.0,"shares_owned_after_display":"3,118,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319936,"accession":"0001418145-07-000002","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-15","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.72,"price_display":"7.72","price_state":"stated","total_value":2316.0,"total_display":"2,316.00","total_whole":"2,316","shares_owned_after":3118906.0,"shares_owned_after_display":"3,118,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319934,"accession":"0001418145-07-000002","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-14","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.69,"price_display":"7.69","price_state":"stated","total_value":2307.0,"total_display":"2,307.00","total_whole":"2,307","shares_owned_after":3119306.0,"shares_owned_after_display":"3,119,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319933,"accession":"0001418145-07-000002","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-13","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.57,"price_display":"7.57","price_state":"stated","total_value":2271.0,"total_display":"2,271.00","total_whole":"2,271","shares_owned_after":3121006.0,"shares_owned_after_display":"3,121,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319931,"accession":"0001418145-07-000002","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-12","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":1598.0,"total_display":"1,598.00","total_whole":"1,598","shares_owned_after":3112006.0,"shares_owned_after_display":"3,112,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319929,"accession":"0001418145-07-000002","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-11","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.86,"price_display":"7.86","price_state":"stated","total_value":1572.0,"total_display":"1,572.00","total_whole":"1,572","shares_owned_after":3116706.0,"shares_owned_after_display":"3,116,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319928,"accession":"0001418145-07-000002","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.79,"price_display":"7.79","price_state":"stated","total_value":1558.0,"total_display":"1,558.00","total_whole":"1,558","shares_owned_after":3118206.0,"shares_owned_after_display":"3,118,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319926,"accession":"0001418145-07-000002","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.76,"price_display":"7.76","price_state":"stated","total_value":1552.0,"total_display":"1,552.00","total_whole":"1,552","shares_owned_after":3118406.0,"shares_owned_after_display":"3,118,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"},{"id":7319924,"accession":"0001418145-07-000002","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001418145-07-000002","line_url":"/filing/0001418145-07-000002#line-8","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283518","owner_name":"Frost Gregory Ian","owner_display_name":"Frost Gregory Ian","owner_url":"/insider/0001283518","role":"Director, Officer (VP and Chief Scientific Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Scientific Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.65,"price_display":"7.65","price_state":"stated","total_value":1530.0,"total_display":"1,530.00","total_whole":"1,530","shares_owned_after":3119693.0,"shares_owned_after_display":"3,119,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-21","scope":"insider"}],"collapsed":true,"next_cursor":"2007-11-20|7319924","ledger_fault":false,"count":{"value":369,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":362,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":369},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001356090","name":"INTREXON CORP","url":"/issuer/0001356090","role":"Officer (SVP--Health Sector)","n_filings":1,"first_seen":"2014-03-04","last_seen":"2014-03-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS INC","url":"/issuer/0001159036","role":"Director, Officer (CEO, President)","n_filings":24,"first_seen":"2004-08-18","last_seen":"2012-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283518","retrieved_at":"2026-08-26T00:06:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}